Forecasting the development of the COVID-19 epidemic by nowcasting:when did things start to get bett

来源 :定量生物学(英文版) | 被引量 : 0次 | 上传用户:xuezhenlong0310
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Background:Now the coronavirus disease 2019(COVID-19)epidemic becomes a global phenomenon and its development concerns billions of peoples'lives.The development of the COVID-19 epidemic in China could be used as a reference for the other countries'control strategy.Methods:We used a classical susceptible-infected-recovered(SIR)model to forecast the development of the COVID-19 epidemic in China by nowcasting.The linear regression analyses were employed to predict the COVID-19 epidemic's inflexion point.Finally,we used a susceptible-exposed-infected-recovered(SEIR)model to simulate the development of the COVID-19 epidemic in China throughout 2020.Results:Our nowcasts show that the COVID-19 transmission rate started to slow down on January 30.The linear regression analyses further show that the inflexion point of this epidemic would arrive between February 17 and 18.The final SEIR model simulation forecasted that the COVID-19 epidemic would probably infect about 82,000 people and last throughout 2020 in China.We also applied our method to USA's and global COVID-19 data and the nowcasts show that the development of COVID-19 pandemic is not optimistic in the rest of 2020.Conclusion:The COVID-19 epidemic's scale in China is much smaller than the previous estimations.After implemented strict control and prevention measures,such as city lockdown,it took a week to slow down the COVID-19 transmission and about four weeks to really mitigate the COVID-19 prevalence in China.
其他文献
目的 建立黄蛭益肾胶囊HPLC指纹图谱,采用指纹图谱并结合化学模式识别技术对黄蛭益肾胶囊进行质量控制.方法 采用Waters XBridge? Shield RP18(250 mm×4.6 mm,5 μm)色谱柱,
以紫杉醇及紫杉醇注射液为例,根据《化学药物杂质研究的技术指导原则》,并参考《中国药典》《美国药典》《欧洲药典》《英国药典》,探讨单一成分药物有关物质质量控制研究要